Effects of Oral Iron on Postoperative Fatigue Upon Coronary Artery Bypass Graft Patients
Status:
Terminated
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to examine how an oral iron supplement (Feramax®)
influences fatigue during early postoperative recovery (at three months) among CABG patients
and, the effects on recovery outcomes (e.g. quality of life, functional capacity, anemia, and
medication adherence).
It is hypothesized that CABG surgery patients receiving oral iron (Feramax®) 150mg orally
(once a day therapy) will have a 15% reduction in POF (measured by the Identity Consequence
Fatigue Scale (ICFS)), compared to patients receiving a placebo.